How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator
WATCH WEBINAR In today’s rapidly evolving pharmaceutical landscape, cognitive safety is emerging as a critical factor that can set products apart in the marketplace. This session will explore the strategic importance of incorporating cognitive assessments as a safety...
From Chance Discovery to Molecular Biology
WATCH WEBINAR Dr. Sheldon H. Preskorn’s presentation, “From Chance Discovery to Molecular Biology,” highlights the evolution of psychiatric drug development, from early chance observations to sophisticated molecular biology approaches. The talk...
Accelerating Clinical & Drug Development Timelines with AI
WATCH WEBINAR As the drug development landscape rapidly evolves, artificial intelligence (AI) is emerging as a transformative force, fundamentally reshaping processes and enhancing efficiencies. This webinar delves into AI’s significant impact on streamlining clinical...
Recent Comments